A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...

"Field tests showed significantly higher yields." Officials make game-changing announcement that could flood grocery shelves ...

New research has found a novel target with therapeutic potential for metastatic eye melanoma—an aggressive eye cancer—with ...

Genome editing technologies like CRISPR-Cas9 have transformed biology, medicine, and agriculture, but concerns remain about ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence.

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing.

A recent study published in Genes & Diseases reveals a novel role of XPR1 in promoting ovarian cancer growth by regulating ...

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.

This innovative software, CRISPRware, optimizes guide RNA design for genome editing, supporting research on genetic disorders ...

CRISPR Therapeutics ’ CRSP first marketed product is the one-shot gene therapy Casgevy, approved in late 2023 and early 2024 across the United States and Europe for two blood disorder ...

The Byers Award recognizes outstanding research by faculty members in the middle of their careers. Martin Kampman’s honorary 2025 lecture is titled “A CRISPR approach to neurodegenerative diseases.” ...

Plants produce a wide diversity of compounds. Broadly, these are separated into primary metabolites, which are necessary for ...